City
Epaper

Tesla, Apple now target 2022 to bolster India manufacturing story

By IANS | Updated: September 28, 2021 12:30 IST

New Delhi, Sep 28 The two big-ticket investments in India this year Tesla and Apple which ...

Open in App

New Delhi, Sep 28 The two big-ticket investments in India this year Tesla and Apple which were set to lift the country as a brand on the world map and further end dependence on China-led investments in the tech and auto sectors, has somewhat been delayed owing to the pandemic and global chip shortage. Nonetheless, both the giants now aim to rewrite their India manufacturing story next year as Covid slows down.

Both Elon Musk and Tim Cook had announced a big-bang entry into the country. Musk wanted his electric cars to run on the domestic roads

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: indiaappleNew DelhiTim CookElon muskSupport companyApple educationThe new delhi municipal councilDelhi south-westApple app stores
Open in App

Related Stories

EntertainmentAjith Kumar Injured in Fan Frenzy After Padma Bhushan Award Ceremony, Actor Hospitalized In Chennai

MumbaiMumbai: Gold Sales Cross ₹12,000 Crores Nationwide on Akshaya Tritiya; Mumbai MMR Sees ₹800 Crores Trade

NationalAkshaya Tritiya 2025: Gold Market Sees Huge Footfall Despite Price Hike (Watch Video)

MaharashtraOver 10,000 Pakistani Nationals Traced in Maharashtra and Delhi Post-Palgham Terror Attack

MumbaiViral Sighting of Tesla Cybertruck Near Mumbai Stirs EV Enthusiasm (Photos)

Technology Realted Stories

TechnologyGene-editing therapy shows promise against advanced colorectal cancer

TechnologyMobile, electronics manufacturers to self-declare Repairability Index: Govt

TechnologyMarket volatility to stay due to geopolitical tensions, Q4 earnings season: Analysts

Technology‘Expo 2025’ in Japan showcases India's growing international presence: Piyush Goyal

TechnologyOver 900 measles cases reported in US so far in 2025: CDC